Canada Markets close in 5 hrs 25 mins

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6732+0.0270 (+4.18%)
As of 10:35AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.0400
52 Week Low 30.4100
50-Day Moving Average 30.5240
200-Day Moving Average 31.1373

Share Statistics

Avg Vol (3 month) 3764.04k
Avg Vol (10 day) 31.34M
Shares Outstanding 5125.5M
Implied Shares Outstanding 6N/A
Float 871.52M
% Held by Insiders 10.42%
% Held by Institutions 146.03%
Shares Short (Apr 28, 2022) 4777.94k
Short Ratio (Apr 28, 2022) 41.58
Short % of Float (Apr 28, 2022) 4N/A
Short % of Shares Outstanding (Apr 28, 2022) 40.62%
Shares Short (prior month Mar 30, 2022) 41.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-8,384.06%

Management Effectiveness

Return on Assets (ttm)-29.10%
Return on Equity (ttm)-74.45%

Income Statement

Revenue (ttm)1.68M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-85.53M
EBITDA -138.11M
Net Income Avi to Common (ttm)-144.58M
Diluted EPS (ttm)-1.2120
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)220.11M
Total Cash Per Share (mrq)1.75
Total Debt (mrq)59.48M
Total Debt/Equity (mrq)28.33
Current Ratio (mrq)6.43
Book Value Per Share (mrq)1.93

Cash Flow Statement

Operating Cash Flow (ttm)-125.1M
Levered Free Cash Flow (ttm)-94.42M